FR2344285B1 - - Google Patents

Info

Publication number
FR2344285B1
FR2344285B1 FR7608004A FR7608004A FR2344285B1 FR 2344285 B1 FR2344285 B1 FR 2344285B1 FR 7608004 A FR7608004 A FR 7608004A FR 7608004 A FR7608004 A FR 7608004A FR 2344285 B1 FR2344285 B1 FR 2344285B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7608004A
Other languages
French (fr)
Other versions
FR2344285A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7608004A priority Critical patent/FR2344285A1/fr
Priority to SE7702908A priority patent/SE436877B/sv
Priority to HU77RO921A priority patent/HU178332B/hu
Priority to ZA00771654A priority patent/ZA771654B/xx
Priority to CA274,256A priority patent/CA1094569A/fr
Priority to IL51690A priority patent/IL51690A/xx
Priority to BE175906A priority patent/BE852624A/xx
Priority to GB11602/77A priority patent/GB1538717A/en
Priority to DK119377A priority patent/DK119377A/da
Priority to CH343677A priority patent/CH620688A5/fr
Priority to ES456999A priority patent/ES456999A1/es
Priority to DE19772711950 priority patent/DE2711950A1/de
Priority to SU772480801A priority patent/SU749364A3/ru
Priority to LU76976A priority patent/LU76976A1/xx
Priority to PT66326A priority patent/PT66326B/pt
Priority to JP2981777A priority patent/JPS52113956A/ja
Priority to NL7703056A priority patent/NL7703056A/xx
Priority to AU23466/77A priority patent/AU506760B2/en
Priority to AT195077A priority patent/AT357275B/de
Priority to IE601/77A priority patent/IE45124B1/en
Publication of FR2344285A1 publication Critical patent/FR2344285A1/fr
Priority to SU782623757A priority patent/SU745366A3/ru
Priority to FR7830054A priority patent/FR2439779A2/fr
Application granted granted Critical
Publication of FR2344285B1 publication Critical patent/FR2344285B1/fr
Priority to AT425979A priority patent/AT371814B/de
Priority to US06/131,053 priority patent/US4279919A/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7608004A 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments Granted FR2344285A1 (fr)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR7608004A FR2344285A1 (fr) 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
SE7702908A SE436877B (sv) 1976-03-19 1977-03-15 Sett att framstella laktonderivat av cyklopentanol
HU77RO921A HU178332B (en) 1976-03-19 1977-03-17 Process for preparing cyclopentanol-lactones
LU76976A LU76976A1 (enrdf_load_stackoverflow) 1976-03-19 1977-03-18
IL51690A IL51690A (en) 1976-03-19 1977-03-18 5-substituted-2-hydroxy-cyclopentane carboxylic or propionic acid lactones,process of preparation and pharmaceutical compositions
BE175906A BE852624A (fr) 1976-03-19 1977-03-18 Nouvelles lactones derivees du cyclopentanol
GB11602/77A GB1538717A (en) 1976-03-19 1977-03-18 Cyclopentanol lactones
DK119377A DK119377A (da) 1976-03-19 1977-03-18 Fremgangsmade til fremstilling af lactonderivater af cyclopentanol
CH343677A CH620688A5 (en) 1976-03-19 1977-03-18 Process for the preparation of new lactones derived from cyclopentanol
ES456999A ES456999A1 (es) 1976-03-19 1977-03-18 Procedimiento de preparacion de nuevas lactonas derivadas del ciclopentanol.
DE19772711950 DE2711950A1 (de) 1976-03-19 1977-03-18 Neue lactone, die sich vom cyclopentanol herleiten, deren herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
SU772480801A SU749364A3 (ru) 1976-03-19 1977-03-18 Способ получени лактонов
ZA00771654A ZA771654B (en) 1976-03-19 1977-03-18 New lactone derivatives of cyclopentanol
CA274,256A CA1094569A (fr) 1976-03-19 1977-03-18 Procede de preparation de nouvelles lactones derivees du cyclopentanol
JP2981777A JPS52113956A (en) 1976-03-19 1977-03-19 Production of novel lactone derivatives of cyclopentanol and pharmaceutical composition
PT66326A PT66326B (pt) 1976-03-19 1977-03-19 Procede de preparation de nouvelles lactones derivees du cyclopentanol
NL7703056A NL7703056A (nl) 1976-03-19 1977-03-21 Werkwijze ter bereiding van nieuwe lactonen van cyclopentanolverbindingen.
AU23466/77A AU506760B2 (en) 1976-03-19 1977-03-21 New lactone derivatives of cyclopentanol proc as for their preparation and pharmaceutical compositions
AT195077A AT357275B (de) 1976-03-19 1977-03-21 Verfahren zur herstellung von neuen lacton- derivaten des cyclopentanols
IE601/77A IE45124B1 (en) 1976-03-19 1977-03-21 Cyclopentanol lactones
SU782623757A SU745366A3 (ru) 1976-03-19 1978-06-08 Способ получени лактона циклопентанкарбоновой кислоты
FR7830054A FR2439779A2 (fr) 1976-03-19 1978-10-23 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
AT425979A AT371814B (de) 1976-03-19 1979-06-15 Verfahren zur herstellung von neuen lactonderivaten des cyclopentanols
US06/131,053 US4279919A (en) 1976-03-19 1980-03-17 Novel lactones of cyclopentanols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7608004A FR2344285A1 (fr) 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
FR2344285A1 FR2344285A1 (fr) 1977-10-14
FR2344285B1 true FR2344285B1 (enrdf_load_stackoverflow) 1979-02-02

Family

ID=9170682

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7608004A Granted FR2344285A1 (fr) 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments

Country Status (20)

Country Link
JP (1) JPS52113956A (enrdf_load_stackoverflow)
AT (1) AT357275B (enrdf_load_stackoverflow)
AU (1) AU506760B2 (enrdf_load_stackoverflow)
BE (1) BE852624A (enrdf_load_stackoverflow)
CA (1) CA1094569A (enrdf_load_stackoverflow)
CH (1) CH620688A5 (enrdf_load_stackoverflow)
DE (1) DE2711950A1 (enrdf_load_stackoverflow)
DK (1) DK119377A (enrdf_load_stackoverflow)
ES (1) ES456999A1 (enrdf_load_stackoverflow)
FR (1) FR2344285A1 (enrdf_load_stackoverflow)
GB (1) GB1538717A (enrdf_load_stackoverflow)
HU (1) HU178332B (enrdf_load_stackoverflow)
IE (1) IE45124B1 (enrdf_load_stackoverflow)
IL (1) IL51690A (enrdf_load_stackoverflow)
LU (1) LU76976A1 (enrdf_load_stackoverflow)
NL (1) NL7703056A (enrdf_load_stackoverflow)
PT (1) PT66326B (enrdf_load_stackoverflow)
SE (1) SE436877B (enrdf_load_stackoverflow)
SU (2) SU749364A3 (enrdf_load_stackoverflow)
ZA (1) ZA771654B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264623A (en) 1978-12-05 1981-04-28 Roussel Uclaf β-Lactones of 2-hydroxy-cyclopentane-carboxylic acids

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2439779A2 (fr) * 1976-03-19 1980-05-23 Roussel Uclaf Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
DE3722133A1 (de) * 1987-07-04 1989-01-12 Bayer Ag Azolyl-tetrahydropyran-derivate
EP1142886A1 (en) * 2000-04-07 2001-10-10 Aventis Pharma Deutschland GmbH Percyquinnin, a process for its production and its use as a pharmaceutical
KR100581647B1 (ko) * 2001-07-17 2006-05-22 파마시아 앤드 업존 캄파니 엘엘씨 라타노프로스트 제조를 위한 방법 및 중간체
CN100417650C (zh) * 2006-08-17 2008-09-10 中国科学院昆明植物研究所 韧革菌素及其制备方法和在药物上的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264623A (en) 1978-12-05 1981-04-28 Roussel Uclaf β-Lactones of 2-hydroxy-cyclopentane-carboxylic acids

Also Published As

Publication number Publication date
CH620688A5 (en) 1980-12-15
SU745366A3 (ru) 1980-06-30
HU178332B (en) 1982-04-28
CA1094569A (fr) 1981-01-27
IE45124B1 (en) 1982-06-30
NL7703056A (nl) 1977-09-21
JPS52113956A (en) 1977-09-24
IL51690A (en) 1982-02-28
BE852624A (fr) 1977-09-19
AU2346677A (en) 1978-09-28
SU749364A3 (ru) 1980-07-15
GB1538717A (en) 1979-01-24
ATA195077A (de) 1979-11-15
FR2344285A1 (fr) 1977-10-14
IL51690A0 (en) 1977-05-31
DE2711950A1 (de) 1977-09-29
JPS62146B2 (enrdf_load_stackoverflow) 1987-01-06
PT66326A (fr) 1977-04-01
PT66326B (pt) 1979-01-18
AU506760B2 (en) 1980-01-24
ES456999A1 (es) 1978-01-16
AT357275B (de) 1980-06-25
LU76976A1 (enrdf_load_stackoverflow) 1977-10-03
SE7702908L (sv) 1977-09-20
SE436877B (sv) 1985-01-28
IE45124L (en) 1977-09-19
ZA771654B (en) 1978-04-26
DK119377A (da) 1977-09-20

Similar Documents

Publication Publication Date Title
FR2359190B1 (enrdf_load_stackoverflow)
FI762907A7 (enrdf_load_stackoverflow)
FR2348486B1 (enrdf_load_stackoverflow)
DK288376A (enrdf_load_stackoverflow)
FR2344285B1 (enrdf_load_stackoverflow)
FR2371751B1 (enrdf_load_stackoverflow)
FI770445A7 (enrdf_load_stackoverflow)
DK22977A (enrdf_load_stackoverflow)
FI53558B (enrdf_load_stackoverflow)
JPS5619188Y2 (enrdf_load_stackoverflow)
FI53236B (enrdf_load_stackoverflow)
JPS5536991Y2 (enrdf_load_stackoverflow)
FI53086C (enrdf_load_stackoverflow)
DK142811C (enrdf_load_stackoverflow)
DK142250C (enrdf_load_stackoverflow)
DK140266C (enrdf_load_stackoverflow)
JPS551152B2 (enrdf_load_stackoverflow)
JPS5621536B2 (enrdf_load_stackoverflow)
JPS5624631B2 (enrdf_load_stackoverflow)
JPS5311788U (enrdf_load_stackoverflow)
JPS5368990U (enrdf_load_stackoverflow)
DK366976A (enrdf_load_stackoverflow)
DK175277A (enrdf_load_stackoverflow)
CS186409B1 (enrdf_load_stackoverflow)
JPS5363807U (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
ST Notification of lapse